RGP (RGP) Q1 2027 Earnings Call Transcript

RGP reported fiscal Q1 2027 revenue of $98.1 million, down 18.5% year over year on a same-day constant-currency basis, with gross margin falling to 37.4% from 39.5% and an $8.0 million net loss versus $2.4 million a year earlier. Adjusted EBITDA was negative $3.6 million as cautious client spending and lower Consulting project volume weighed on results, while adjusted SG&A improved 9.4% to $40.3 million. Management expects Q2 revenue of $95 million to $100 million and gross margin of 36% to 37%; the company ended the quarter with $61.2 million in cash, no debt, and paid a $0.07-per-share quarterly dividend.

Analysis

The key issue is conversion, not stated demand: pipeline growth and stronger strategic accounts have not translated into closed wins or project starts. If that gap persists, sales hiring and targeted reinvestment raise the risk that costs arrive before revenue, while low consultant utilization continues to dilute gross margin. Flat Q2 revenue guidance and a lower seasonal margin outlook leave little near-term operating leverage to absorb another miss.

The counterpoint is that the balance sheet provides time for a recovery, and pricing in On-Demand Talent and Consulting is holding up; this looks more like a volume/utilization problem than broad-based price capitulation. But “stabilizing” is not yet evidence of a turn. AI efficiency claims are also not a near-term offset until savings show up in recurring costs or client revenue. Interim finance leadership adds execution risk, though it is not by itself a thesis.

Over 1–3 months, watch closed-won dollars, project starts, salaried utilization, and whether sales hires produce measurable wins. Over 6–18 months, sustained utilization recovery could restore operating leverage; continued weak starts would make cost reductions and dividend capacity more consequential. Staffing peers such as Robert Half (RHI) and Kforce (KFRC) are useful demand read-throughs, not automatic beneficiaries: the same discretionary-spend caution can affect them. Contrarian view: a prolonged slump may make any sequential improvement look more meaningful than it is; require conversion and margin evidence before treating a bottom as established.

Key Decisions for Investors

• No high-conviction directional trade from this call alone: avoid buying a recovery narrative until closed-won activity and utilization improve, and avoid an unhedged short without valuation and borrow data.
• For existing RGP exposure, keep sizing defensive and reassess after the next results: track project starts, billable hours/utilization, gross margin, and cash after dividends and restructuring/transition costs.
• Consider a tactical underweight or short-on-strength only if subsequent reporting shows revenue below the $95–$100 million Q2 range, utilization remains in the high-50% area or falls, or gross margin misses the 36%–37% outlook; cap risk around evidence of sequential conversion and improving margins.
• Falsification of the cautious thesis: sustained sequential growth in closed-won dollars and project starts, higher utilization, and gross-margin improvement beyond seasonal effects. Verify cash-flow and dividend coverage in filings; headline cash and revolver availability alone do not establish the durability of distributions.